Breast Cancer Awareness Month

United States, Canada, United Kingdom, Australia, New Zealand, Ireland, South Africa, India, Pakistan, Bangladesh, Singapore, Malaysia, Philippines, Japan, South Korea, China, Thailand, Indonesia, Brazil, Mexico, Argentina, Chile, Colombia, Peru, France, Germany, Spain, Italy, Portugal, Netherlands, Belgium, Switzerland, Austria, Sweden, Norway, Denmark, Finland, Poland, Greece, Turkey, United Arab Emirates, Saudi Arabia, Israel, Nigeria, Kenya, Ghana, Egypt

About

Breast Cancer Awareness Month is observed throughout October as a time to increase understanding of breast cancer, promote education, and encourage people to be attentive to their breast health. It highlights the importance of learning about risk factors, recognizing potential warning signs, discussing concerns with healthcare professionals, and following recommended screening guidance.

Throughout the month, communities come together to honor those affected by breast cancer, remember loved ones lost, and celebrate survivors. Awareness campaigns, educational events, fundraising efforts, and acts of support help advance research, expand access to care, and remind individuals and families that compassion, early attention, and support can make a meaningful difference.

History

Breast Cancer Awareness Month is observed throughout October and began in the United States in 1985 as a collaboration between the American Cancer Society and the pharmaceutical division of Imperial Chemical Industries. The early campaign focused on educating the public about breast cancer and encouraging women to discuss screening, particularly mammography, with health-care professionals. At the time, public knowledge about the disease was more limited, and discussing breast health openly was often difficult. The observance helped bring breast cancer into public conversation and presented early detection as an important part of reducing mortality.

During the late 1980s and 1990s, the campaign grew beyond a medical education effort into a broad public-health movement. Advocacy organizations, hospitals, charities, businesses, and government agencies began using October to promote research funding, screening access, patient support, and improved treatment. The pink ribbon became the observance’s most recognizable emblem in the early 1990s, particularly through the work of Evelyn H. Lauder and the Estée Lauder Companies. Its widespread adoption gave breast cancer campaigns a common visual identity and helped fundraising and awareness messages reach much larger audiences.

Over time, Breast Cancer Awareness Month has evolved to address a wider range of issues than screening alone. Public campaigns now emphasize the importance of understanding personal risk, recognizing symptoms, receiving timely diagnostic care, and supporting people throughout treatment and recovery. They also draw attention to genetic risk, advances in surgery and drug therapies, survivorship, metastatic breast cancer, male breast cancer, and the unequal burdens experienced by racial, ethnic, rural, and low-income communities. This broader focus reflects increased recognition that awareness must be connected to affordable care, accurate information, research, and tangible support.

Culturally, the observance has made breast cancer one of the most visible diseases in public life and has encouraged patients and survivors to share their experiences. Fundraising walks, educational events, pink-themed campaigns, and memorial activities have created widely recognized traditions, while advocacy groups have used the month to press for research and health-policy changes. At the same time, its history has prompted discussion about “pinkwashing,” commercialization, privacy, and whether awareness campaigns adequately represent people living with advanced disease. As a result, Breast Cancer Awareness Month continues to combine remembrance and solidarity with calls for prevention, equitable treatment, scientific progress, and meaningful support for everyone affected by breast cancer.

Timeline

1982
Nancy G. Brinker founded the Susan G. Komen Breast Cancer Foundation in memory of her sister, Susan G. Komen. The organization became a major force in breast-cancer research funding and public awareness.
1991
The Susan G. Komen Foundation distributed pink ribbons to participants in its New York City Race for the Cure, helping establish the pink ribbon as a prominent breast-cancer-awareness symbol.
1993
The National Breast Cancer Coalition was founded in the United States, bringing together advocates and organizations to press for breast-cancer research, access to care, and public-policy action.
1998
The U.S. Food and Drug Administration approved trastuzumab (Herceptin) for treatment of metastatic HER2-positive breast cancer, a landmark targeted therapy for the disease.

Upcoming dates

Sources

Same day

Related